SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

H.C. Wainwright Reiterates Buy on INmune Bio, Raises Price Target to $8

H.C. Wainwright analyst Swayampakula Ramakanth reiterates INmune Bio (NASDAQ:INMB) with a Buy and raises the price target from $7 to $8.

Benzinga · 05/15/2020 11:10

H.C. Wainwright analyst Swayampakula Ramakanth reiterates INmune Bio (NASDAQ:INMB) with a Buy and raises the price target from $7 to $8.